AssetMark Inc’s Elanco Animal Health ELAN Stock Holding History

AssetMark Inc’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$29.1K	Buy	1,299 +67	+5%	+$1.62K	﹤0.01%	2104
2026 Q2	$30.3K	Buy	1,232 +399	+48%	+$9.22K	﹤0.01%	2031
2026 Q1	$19.9K	Sell	833 -38	-4%	-$929	﹤0.01%	2055
2025 Q4	$19.7K	Buy	871 +117	+16%	+$2.55K	﹤0.01%	2012
2025 Q3	$15.2K	Buy	754 +490	+186%	+$8.21K	﹤0.01%	2002
2025 Q2	$3.77K	Buy	264 +111	+73%	+$1.3K	﹤0.01%	2223
2025 Q1	$1.61K	Sell	153 -42	-22%	-$475	﹤0.01%	2217
2024 Q4	$2.36K	Buy	195 +68	+54%	+$890	﹤0.01%	2083
2024 Q3	$1.87K	Buy	127 +96	+310%	+$1.34K	﹤0.01%	1893
2024 Q2	$447	Sell	31 -2	-6%	-$32	﹤0.01%	1933
2024 Q1	$537	Buy	33 +17	+106%	+$266	﹤0.01%	1721
2023 Q4	$238	Buy	+16	New	+$181	﹤0.01%	1747
2023 Q1	–	Sell	-18	Closed	-$220	–	1622
2022 Q4	$220	Hold	18	–	–	﹤0.01%	1540
2022 Q3	$0	Hold	18	–	–	﹤0.01%	1548
2022 Q2	$0	Hold	18	–	–	﹤0.01%	1524
2022 Q1	$0	Hold	18	–	–	﹤0.01%	1605
2021 Q4	$1K	Hold	18	–	–	﹤0.01%	1424
2021 Q3	$1K	Hold	18	–	–	﹤0.01%	1315
2021 Q2	$1K	Buy	+18	New	+$594	﹤0.01%	1242

Other funds holding ELAN

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.92% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

DDD Partners Bellevue, Washington $1.75B AUM 20.59% 1-Year Est. Return

AssetMark Inc's ELAN Position: Q3 2026 in Review

AssetMark Inc increased its Elanco Animal Health (ELAN) stake by 5.4% in Q3 2026, buying an estimated $1.62K and bringing the position to 1,299 shares worth $29.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2104.

AssetMark Inc first reported a position in ELAN in Q2 2021 and has held it in 19 quarters since. The position peaked at $30.3K in Q2 2026. 242 funds tracked by Wall St. Rank hold ELAN as of Q3 2026.

AssetMark Inc held 1,299 shares of Elanco Animal Health worth $29.1K as of Q3 2026.
AssetMark Inc bought 67 Elanco Animal Health shares in Q3 2026, an estimated $1.62K.
Elanco Animal Health made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #2104 holding.
AssetMark Inc first reported a position in Elanco Animal Health in Q2 2021 and has held it in 19 quarters since.
AssetMark Inc's Elanco Animal Health position peaked at $30.3K in Q2 2026.
242 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.